ZUCCA, SUSANNA
 Distribuzione geografica
Continente #
NA - Nord America 2.569
AS - Asia 2.062
EU - Europa 1.727
SA - Sud America 360
AF - Africa 21
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 1
Totale 6.745
Nazione #
US - Stati Uniti d'America 2.500
CN - Cina 1.158
IE - Irlanda 446
SG - Singapore 400
BR - Brasile 310
IT - Italia 277
RU - Federazione Russa 250
HK - Hong Kong 231
DE - Germania 203
FI - Finlandia 198
UA - Ucraina 128
VN - Vietnam 118
GB - Regno Unito 59
SE - Svezia 37
CA - Canada 33
FR - Francia 30
IN - India 29
MX - Messico 26
BE - Belgio 22
BD - Bangladesh 20
AR - Argentina 19
ES - Italia 19
EC - Ecuador 17
JP - Giappone 17
IQ - Iraq 15
PL - Polonia 14
NL - Olanda 12
TR - Turchia 12
ID - Indonesia 9
ZA - Sudafrica 9
CZ - Repubblica Ceca 7
IL - Israele 6
UZ - Uzbekistan 6
AT - Austria 5
CO - Colombia 5
EU - Europa 4
IR - Iran 4
LT - Lituania 4
MA - Marocco 4
PK - Pakistan 4
AL - Albania 3
AZ - Azerbaigian 3
KR - Corea 3
KW - Kuwait 3
LK - Sri Lanka 3
LV - Lettonia 3
PS - Palestinian Territory 3
SA - Arabia Saudita 3
TN - Tunisia 3
CH - Svizzera 2
CL - Cile 2
DZ - Algeria 2
EG - Egitto 2
JM - Giamaica 2
KG - Kirghizistan 2
MY - Malesia 2
NP - Nepal 2
PA - Panama 2
PE - Perù 2
QA - Qatar 2
UY - Uruguay 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BG - Bulgaria 1
BY - Bielorussia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
GE - Georgia 1
HN - Honduras 1
HR - Croazia 1
JO - Giordania 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MD - Moldavia 1
NI - Nicaragua 1
NO - Norvegia 1
PH - Filippine 1
PT - Portogallo 1
PY - Paraguay 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TG - Togo 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.745
Città #
Dublin 445
Chandler 378
Dallas 276
Jacksonville 237
Nanjing 236
Hong Kong 229
Singapore 214
Beijing 200
Ashburn 167
Boardman 127
New York 112
Pavia 110
Nanchang 101
Changsha 79
Helsinki 78
Dearborn 77
Los Angeles 72
Munich 69
Lawrence 67
Medford 67
Princeton 67
Shenyang 65
Ann Arbor 59
Hebei 59
Wilmington 59
Jiaxing 52
Moscow 52
Shanghai 50
Hangzhou 44
Tianjin 38
Ho Chi Minh City 37
Redondo Beach 37
São Paulo 30
Turku 30
Hanoi 28
Buffalo 24
Seattle 22
Brussels 21
Milan 21
Tokyo 17
Toronto 16
Kunming 14
Piscataway 14
Brooklyn 12
Denver 12
Mexico City 12
Norwalk 12
Orem 12
San Francisco 12
Warsaw 12
Guangzhou 11
Stockholm 11
Turin 11
Fairfield 10
Jinan 10
London 10
Santa Clara 10
Boston 9
Ningbo 9
Rome 9
Biên Hòa 8
Chennai 8
Chicago 8
Dhaka 8
Falkenstein 8
Montreal 8
Woodbridge 8
Atlanta 7
Brasília 7
Charlotte 7
Genzano Di Roma 7
Manchester 7
Orange 7
Phoenix 7
Poplar 7
Salvador 7
Xi'an 7
Brescia 6
Curitiba 6
Guayaquil 6
Haiphong 6
Novara 6
Nuremberg 6
Rio de Janeiro 6
Tashkent 6
The Dalles 6
Genoa 5
Mumbai 5
Quito 5
Amsterdam 4
Ankara 4
Berlin 4
Council Bluffs 4
Da Nang 4
Düsseldorf 4
Florence 4
Frankfurt am Main 4
Gandía 4
Guarulhos 4
Houston 4
Totale 4.620
Nome #
A comparison of eVai, CADD and VVP variant prediction results on the ICR639 hereditary cancer dataset 170
Analysis of amplicon-based NGS data from neurological disease gene panels: a new method for allele drop-out management 160
Phenotypes extraction from clinical descriptions using Large Language Models 139
DIVAs: a phenotype-based machine-learning model to assess the pathogenicity of digenic variant combinations 129
A standard vector for the chromosomal integration and characterization of BioBrick™ parts in Escherichia coli 125
Ethanol? Whey not! 124
A BioBrick-compatible Vector for Allelic Replacement Using the XylE Gene as Selection Marker 120
Bottom-up engineering of biological systems through standard bricks: a modularity study on basic parts and devices 118
A methodology for the reliable analysis of amplicon-based NGS data 118
Characterization of a synthetic bacterial self-destruction device for programmed cell death and for recombinant proteins release 113
Biologia sintetica e standardizzazione: verso la programmazione razionale di funzioni biologiche artificiali 113
Conversion of industrial bio-waste into biofuels through Syntetic Biology supported by flow cytometry 110
Design and implementation of a negative feedback controller in E. coli with a bottom-up approach 106
Modeling the effects of promoter and regulator copy number variation on the output of inducible systems in engineered genetic circuits 105
Characterization of promoter strength varying the DNA copy number from one to hundreds of copy 105
Characterization of a synthetic luxR-HSL repressible promoter for the design of novel activation-repression circuits in E. coli 104
Bottom-up design of genetic circuits: characterization and re-use of biological building blocks to engineer predictable systems 104
Characterization of promoter strength at different DNA copy numbers using RPUs 101
Characterization of an inducible promoter in different DNA copy number conditions 100
Characterization of promoter strength at different DNA copy numbers using RPU approach 99
Methods and tools for multiscale modelling in Systems Pharmacology: a review 99
Definition and in vivo evaluation of mathematical models to predict the effects of copy number variations and cell burden in interconnected synthetic circuits 99
CTRL + E.: Signalling is Nothing Without Control 99
Studying the effects of cell-to-cell viariability on the quantitative behaviour of synthetic biological networks through stochastic simulations 98
Interconnection of quantitatively characterized genetic devices to engineer predictable biological functions 96
A Synthetic Close-Loop Controller Circuit for the Regulation of an Extracellular Molecule by Engineered Bacteria 96
Half-life measurements of chemical inducers for recombinant gene expression 95
Alzheimer's, Parkinson's Disease and Amyotrophic Lateral Sclerosis Gene Expression Patterns Divergence Reveals Different Grade of RNA Metabolism Involvement 93
Mathematical model-based prediction of metabolic burden effects in interconnected synthetic gene circuits 92
Characterization of regulatory parts for the metabolic engineering of E. coli and B. subtilis: applications in the conversion of bio-waste into biofuels and bioproducts 92
Leukocite derived microvescicles as disease progression biomarkers in slow progressing amyotrophic lateral sclerosis. 92
Molecular Genetics and Interferon Signature in the Italian Aicardi Goutières Syndrome Cohort: Report of 12 New Cases and Literature Review 92
DIVAs, a phenotype-driven machine-learning model to assess the pathogenicity 92
Multi-Faceted Characterization of a Novel LuxR-Repressible Promoter Library for Escherichia coli 90
Engineering synthetic biological circuits with predictable function: experimentaland computational studies 89
Gene silencing via small RNAs: fine tuning of synthetic biological circuits and metabolic pathways 89
GCConverter: a new tool for genomic coordinates conversion 86
PREDICTIVE METHOD FOR DETERMINING THE PATHOGENICITY OF COMBINATIONS OF DIGENIC OR OLIGOGENIC VARIANTS 85
Efficient conversion of industrial bio-waste into biofuels and bioproducts through E. coli and B. subtilis synthetic biology 85
Quantitative study of model systems to test the modularity of parts in synthetic biology 82
Design, realization and characterization of a libray of repressible transcritional promoters 81
Mathematical model-based modular design of genetic circuits to express a target protein at a desired mean and cell-to-cell variability level 81
Methodologies for the reliable analysis of amplicon-based NGS data managing allele drop-out artefacts 81
Synthetic Biology Approaches for the Rational Engineering of Novel E. coli and B. subtilis Biocatalysts for the Conversion of Industrial Bio-Waste into Biofuels and Bioproducts 81
Validation of a standard approach for quantitative characterization of promoter strength 79
ProteInProgress 79
POLY-GAMMA-GLUTAMIC ACID PRODUCTION IN ENGINEERED BACILLUS SUBTILIS STRAIN: Valorization of agro-industrial by-products as Bacillus feedstock 79
RNA-seq profiling in peripheral blood mononuclear cells of amyotrophic lateral sclerosis patients and controls 79
Study of an inducible lysis device in E. coli 78
Sharable quantitative measurements of biological parts using the Relative Promoter Units approach 78
Modelling and implementation of a negative feedback mechanism in E. coli 77
Modelling for Synthetic Biology 77
Engineering E. coli chromosome through BBa_K300000, a BioBrick integrative base vector 76
Engineering an alcoholic fermentation pathway in E. coli using the Synthetic Biology approach 75
Realization of a double knob in Escherichia coli to optimize fermentation of lactose of dairy whey into ethanol 74
Evaluation of sequence-to-function predictive tools to support the bottom-up design of complex genetic circuits in synthetic biology 74
In vivo and in silico approaches to study the effects of copy number variationon gene networks behaviour 72
ViR: a tool to solve intrasample variability in the prediction of viral integration sites using whole genome sequencing data 72
Modelling the effects of copy number variation in synthetic gene networks 71
Study of a genetic negative feedback controller via bottom-up approach and mathematical modelling 71
Evaluation of different constraint-based methods to predict the growth of Escherichia coli in different environmental and genetic conditions 70
Fermentation of lactose to ethanol in cheese whey permeate and concentrated permeate by engineered \em Escherichia coli 69
Digenic variant interpretation with hypothesis-driven explainable AI 66
COVID-19 patients and Dementia: Frontal cortex transcriptomic data 65
AI Models Predicting Methylation Status from DNA Sequence: What is Missing? 65
An AI-based approach driven by genotypes and phenotypes to uplift the diagnostic yield of genetic diseases 63
A machine learning approach based on ACMG/AMP guidelines for genomic variant classification and prioritization 62
A machine learning approach for the detection of incidental findings in genetic testing 61
Predictable Design in Biological Engineering: Debugging of Synthetic Circuits By in Vivo and in silico Approaches 61
Phenotypic Variation in Two Siblings Affected with Shwachman-Diamond Syndrome: The Use of Expert Variant Interpreter (eVai) Suggests Clinical Relevance of a Variant in the KMT2A Gene 58
Modelling and implementing a negative feedback-loop in Escherichia coli 56
Validation of a workflow for the detection of small copy number variation from gene panels NGS data 56
Differential Neuropathology, Genetics, and Transcriptomics in Two Kindred Cases with Alzheimer's Disease and Lewy Body Dementia 54
Critical assessment of variant prioritization methods for rare disease diagnosis within the rare genomes project 53
Modelling the effects of cell-to-cell variability on the output of interconnected gene networks in bacterial populations 53
Re-using biological devices: a model-aided analysis of interconnected transcriptional cascades designed from the bottom-up 52
Standard measurements in Synthetic Biology: towards the rational design of novel biological functions 51
eVai's Suggested Diagnosis feature: a new AI-based method to increase diagnostic yield in Rare Disease Patients 48
Experimental measurements and mathematical modeling of biological noise arising from transcriptional and translational regulation of basic synthetic gene circuits 48
Totale 6.850
Categoria #
all - tutte 26.693
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.693


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021224 0 0 0 0 0 30 5 70 26 60 28 5
2021/2022335 5 1 13 5 3 6 9 25 19 5 56 188
2022/20231.161 115 105 12 88 100 93 7 54 510 19 34 24
2023/2024526 46 84 13 34 36 143 19 31 2 16 32 70
2024/20251.325 27 95 31 29 46 63 47 72 333 50 170 362
2025/20261.756 265 291 404 418 342 36 0 0 0 0 0 0
Totale 6.850